Review article · 2025 · Open access
Damage-associated molecular patterns (DAMPs) in diseases: implications for therapy
Molecular Biomedicine, 6(1), 60 · Published 28 August 2025 · DOI 10.1186/s43556-025-00305-3
In brief
“Damage-associated molecular patterns (DAMPs) in diseases: implications for therapy” is a 2025 review article by Heya Lin and 4 co-authors, published in Molecular Biomedicine. OpenAlex counts 143 citations as of 15 November 2026. It is open access under a CC BY licence: the full text is free to read at Molecular Biomedicine.
- Citations
- 143
- Most cited in
- 2026 (132)
- Field-weighted impact
- 10.18
- References
- 466
- Authors
- 5
Abstract
Damage-associated molecular patterns (DAMPs) are endogenous danger signal molecules released by damaged, stressed or dead cells that bind to pattern recognition receptors (PRRs), activating immune responses and inflammatory signaling pathways to play critical regulatory roles in various pathophysiological processes. This review classifies DAMPs into three major categories (protein-based, nucleic acid-based and mitochondria-derived) based on distinct molecular characteristics and biological functions, analyzing their structural features and functional differences. We systematically summarize current understanding of DAMP molecular transformation mechanisms, release pathways and recognition processes, with in-depth discussion of their pathological roles in major diseases including cancer, cardiovascular diseases and respiratory disorders. Particular emphasis is placed on the molecular recognition mechanisms between DAMPs and PRRs (TLRs, NLRs, CLRs and RAGE), and the disease regulatory networks formed by activated key signaling pathways (NF-κB, MAPK, inflammasomes and cGAS-STING). Current DAMP/PRR-targeted therapeutic strategies are comprehensively reviewed, including: modulating cell death pathways to reduce DAMP release, neutralizing DAMP activity using monoclonal antibodies, developing small-molecule inhibitors to block signaling pathways, and employing enzymatic degradation or gene silencing technologies for precise intervention. While showing promise in inflammatory and cancer disease models, these approaches face clinical translation challenges including DAMP molecular heterogeneity, inefficient drug delivery systems, and the complexity of multi-target synergistic mechanisms. Potential solutions involving nanoparticle delivery systems, AI-driven personalized treatment optimization and gene editing technologies are discussed. This review aims to provide references for developing novel therapeutics targeting the DAMP/PRR signaling axis, potentially opening new treatment avenues for cancer, neurodegenerative diseases, cardiovascular diseases and inflammatory disorders.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Lin, H., Xiong, W. G., Fu, L., Yi, J., & Yang, J. (2025). Damage-associated molecular patterns (DAMPs) in diseases: implications for therapy. Molecular Biomedicine, 6(1), 60. https://doi.org/10.1186/s43556-025-00305-3
MLA 9
Lin, Heya, et al. “Damage-associated molecular patterns (DAMPs) in diseases: implications for therapy.” Molecular Biomedicine, vol. 6, no. 1, 2025, p. 60. https://doi.org/10.1186/s43556-025-00305-3.
Chicago
Lin, Heya, Wei Guo Xiong, Lili Fu, Jie Yi, and Jiantang Yang. 2025. “Damage-associated molecular patterns (DAMPs) in diseases: implications for therapy.” Molecular Biomedicine 6 (1): 60. https://doi.org/10.1186/s43556-025-00305-3.
Harvard
Lin, H. et al. (2025) ‘Damage-associated molecular patterns (DAMPs) in diseases: implications for therapy’, Molecular Biomedicine, 6(1), p. 60. doi:10.1186/s43556-025-00305-3.
IEEE
H. Lin, W. G. Xiong, L. Fu, J. Yi, and J. Yang, “Damage-associated molecular patterns (DAMPs) in diseases: implications for therapy,” Molecular Biomedicine, vol. 6, no. 1, p. 60, 2025, doi: 10.1186/s43556-025-00305-3.
BibTeX
@article{lin2025damage,
title = {{Damage-associated molecular patterns (DAMPs) in diseases: implications for therapy}},
author = {Lin, Heya and Xiong, Wei Guo and Fu, Lili and Yi, Jie and Yang, Jiantang},
journal = {Molecular Biomedicine},
year = {2025},
volume = {6},
number = {1},
pages = {60},
doi = {10.1186/s43556-025-00305-3},
url = {https://doi.org/10.1186/s43556-025-00305-3}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2016 | 1 | |
| 2025 | 10 | |
| 2026 | 132 |
Its field-weighted citation impact is 10.18: it has been cited 10.18 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- damage-associated molecular patterns
- pattern recognition receptors
- Toll-like receptors
- NOD-like receptors
- C-type lectin
- RAGE
- NF-κB signaling
- MAPK signaling
Work with this paper
Most-cited papers in Immunology and Microbiology
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Ulrich K. Laemmli · Nature · 1970 · 249,784 citations
- Atherosclerosis — An Inflammatory DiseaseRussell Ross · New England Journal of Medicine · 1999 · 21,957 citations
- Continuous cultures of fused cells secreting antibody of predefined specificityGeorges Köhler, César Milstein · Nature · 1975 · 17,450 citations
- Inflammation and cancerLisa M. Coussens, Zena Werb · Nature · 2002 · 15,462 citations
- Dendritic cells and the control of immunityJacques Banchereau, Ralph M. Steinman · Nature · 1998 · 14,526 citations
Questions about this paper
How do I cite this paper in APA style?
Lin, H., Xiong, W. G., Fu, L., Yi, J., & Yang, J. (2025). Damage-associated molecular patterns (DAMPs) in diseases: implications for therapy. Molecular Biomedicine, 6(1), 60. https://doi.org/10.1186/s43556-025-00305-3
How many times has this paper been cited?
143 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access: read the free full text at Molecular Biomedicine.
Who wrote this paper?
Heya Lin, Wei Guo Xiong, Lili Fu, Jie Yi, Jiantang Yang.
What is the DOI of this paper?
10.1186/s43556-025-00305-3. The permanent link is https://doi.org/10.1186/s43556-025-00305-3.
Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.